Delivery Order SPE2DB22D3501-SPE2DB25FVJ04

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,655.48 and a performance period ending on June 11, 2025. The contract is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp also...
This federal contract award, valued at $4,266.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ferumoxytol 510 mg/17 ml vials, a specialty medication, with a completion date of September 10, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ1GW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,172,431 units of the pharmaceutical product Ferumoxytol 510 mg/17 ml vial, 17 ml, with a ceiling value of $3,996.92. The contract is a Firm Fixed Price Delivery Order, with a performance period through May 8, 2025. This award is not...
This is a $2,170.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 510 mg/17 ml ferumoxytol vials, a medication used to treat iron deficiency anemia. The contract is not a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical. This...
This federal contract award is for the delivery of Ferumoxytol 510 mg/17 ml vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $1,079.84. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 510 mg/17 ml ferumoxytol vials, a medical product used in the treatment of iron deficiency anemia. The contract has a ceiling value of $7,889.01 and a period of performance through April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 510 mg/17 ml ferumoxytol vials, a pharmaceutical product used for the treatment of iron deficiency anemia. The contract has a firm fixed price and a ceiling value of $2,702.00. It is a non-set-aside contract, indicating open competition. The contract has an ultimate...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 510 mg/17 ml vials of the drug ferumoxytol, a medication used to treat iron deficiency anemia. The contract has a ceiling value of $5,071.17 and a period of performance through April 16, 2025. It is a firm-fixed price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 mL vials of the pharmaceutical product Ferumoxytol, with a ceiling value of $2,434.84 and a period of performance through May 29, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVJ04
    Delivery Order

This federal contract award, valued at $2,161.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a pharmaceutical product, with a performance period extending to April 2025.

The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, held by Amerisourcebergen Drug Corp with DLA Troop Support Medical. This IDC, valued at $999,999,999.00, provides a comprehensive global pharmaceutical support mechanism for the DLA, Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026. The contract does not have a set-aside designation, indicating open competition.

Generated 7/18/25, 10:07 AM